Skip to main content
. 2013 May 28;6:603–608. doi: 10.2147/OTT.S44505

Figure 1.

Figure 1

Dose-survival curves of the A973 cells after irradiation with or without erlotinib, based on different administration schedules. (A) Radiation groups; (B) groups receiving irradiation before erlotinib administration; (C) groups receiving simultaneous irradiation and erlotinib administration; and (D) groups receiving irradiation after erlotinib administration.